Surgical staging in endometrial cancer

MJ Mourits*, JG Aalders

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

Abstract

Endometrial cancer is the most prevalent cancer of the female genital tract. No randomised study exists to prove that pelvic and para-aortic lymphadenectomy increases survival, either by dissecting micrometastases or by altering the adjuvant treatment in all early stage (stage I grade I and 2) endometrial cancer patients. For lymph node metastases, adverse histology, deep myometrial invasion and cervical involvement are independent prognostic factors. We discuss the indication for full surgical staging in early endometrial cancer. In case a lymphadenectomy is indicated, this should always include a full pelvic and para-aortic lymphadenectomy. Lymphadenectomy does not replace adjuvant radiotherapy. (c) 2005 Elsevier B.V. All rights reserved.

Original languageEnglish
Title of host publicationGynaecology, Obstetrics, and Reproductive Medicine in Daily Practice
EditorsE Slager, B Fauser, H VanGeijn, H Brolmann, H Vervest
Place of PublicationAMSTERDAM
PublisherElsevier
Pages158-161
Number of pages4
ISBN (Print)0-444-51917-3
DOIs
Publication statusPublished - 2005
Event15th Congress of Gynaecology, Obstetrics and Reproductive Medicine - , Netherlands
Duration: 6-Apr-20058-Apr-2005

Publication series

NameINTERNATIONAL CONGRESS SERIES
PublisherELSEVIER SCIENCE BV
Volume1279
ISSN (Print)0531-5131

Other

Other15th Congress of Gynaecology, Obstetrics and Reproductive Medicine
CountryNetherlands
Period06/04/200508/04/2005

Keywords

  • endometrial cancer
  • surgical staging
  • lymphadenectomy
  • pelvic
  • para-aortic
  • GYNECOLOGIC-ONCOLOGY-GROUP
  • PELVIC LYMPHADENECTOMY
  • MANAGEMENT
  • CARCINOMA
  • CTF
  • PET

Cite this